Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 6,829.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 6,829.44% |
Sezzle Inc Common Stock (SEZL) | 127.44% |
IHS (IHS) | 114.04% |
Dave (DAVE) | 107.35% |
H&E Equipment Services (HEES) | 94.18% |
TransMedics (TMDX) | 90.78% |
Oklo (OKLO) | 87.14% |
Root (ROOT) | 86.41% |
Hertz Global (HTZ) | 80.86% |
Harmony Gold Mining (HMY) | 76.48% |
Inter & Co Inc Class A Common Shares (INTR) | 70.49% |
Soleno Therapeutics (SLNO) | 68.71% |
Orla Mining (ORLA) | 68.51% |
Companhia Paranaense de Energia - COPEL (ELPC) | 66.95% |
StoneCo (STNE) | 66.29% |
Metsera, Inc Common Stock (MTSR) | 60.89% |
TIM Participacoes (TIMB) | 58.84% |
Millicom International Cellular (TIGO) | 56.99% |
Embotelladora Andina (AKO.B) | 56.74% |
iRhythm Technologies (IRTC) | 56.63% |
Nextracker Inc Class A Common Stock (NXT) | 56.03% |
Companhia Paranaense de Energia Pref ADR (ELP) | 55.97% |
New Gold (NGD) | 55.38% |
Verona Pharma PLC ADR (VRNA) | 55.35% |
D-Wave Quantum (QBTS) | 54.71% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
